How do I subscribe to ongoing alerts?

Subscribe to /feed/company/groupe-d-etude-sur-le-risque-d-exposition-des-soignants-aux-agents-infectieux.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux pipeline: 1 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Genvoya	Genvoya	marketed			Other
raltegravir (Isentress)	raltegravir (Isentress)	phase 3	Integrase strand transfer inhibitor (INSTI)	HIV integrase	Infectious Disease

Therapeutic area mix

Infectious Disease · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

ANRS, Emerging Infectious Diseases · 1 shared drug class
Abbott · 1 shared drug class
Desmond Tutu HIV Foundation · 1 shared drug class
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal · 1 shared drug class
Germans Trias i Pujol Hospital · 1 shared drug class
MU-JHU CARE · 1 shared drug class
Massachusetts General Hospital · 1 shared drug class
Merck Sharp & Dohme LLC · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux:

Cite this brief

Drug Landscape (2026). Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/groupe-d-etude-sur-le-risque-d-exposition-des-soignants-aux-agents-infectieux. Accessed 2026-05-17.